Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to keep kids with heart disease safe at home

NCT ID NCT06034392

Knowledge-focused Sponsor: Lori Erickson Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a mobile app called CHAMP that lets parents of children with complex congenital heart disease enter health data and upload photos or videos from home. The goal is to see if the app helps doctors monitor the child's condition remotely and improve communication with families. Up to 1,000 children and their parents will take part across multiple hospitals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CHAMP App (mobile software application)
What this could lead to
If successful, this app could help doctors monitor children with heart conditions from home, potentially reducing hospital visits and improving care.
What could go wrong
This is an early-stage study focused on usability and safety, not on curing or treating the disease. The app itself does not monitor the child's condition directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pediatric patients with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated in the home setting through a multi-regional approach. Parents who utilize their CHAMP App and the healthcare team that log-in are also part of the CHAMP App study.

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 0-17 years with a parent/Legally authorized representative * Diagnosed with a complex health condition in which asynchronous monitoring in the home setting is appropriate. * Pediatric patient's cardiac care team has decided that the patient's treatment plan may benefit from remote home monitoring. * Institution that the subject is followed through clinically has been an approved as site for the CHAMP app study with Children's Mercy Kansas City. Adult participants * Parents/Legally authorized representatives of pediatric subject. * Healthcare team users at an institution that is an approved site for the CHAMP app Study with Children's Mercy Kansas City. Exclusion Criteria: * Inability to be discharged to care in the home setting. * Those not meeting the above inclusion criteria.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart defects, congenital are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

congenital heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart defects, congenital Pediatrics

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Hospital New Orleans

    New Orleans, Louisiana, 70118, United States

  • Children's Memorial Hermann Hospital

    Houston, Texas, 77030, United States

  • Children's Mercy Hospital

    Kansas City, Missouri, 64108, United States

  • Children's National Hospital

    Washington D.C., District of Columbia, 20010, United States

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45219, United States

  • Cook's Children's

    Forth Worth, Texas, 76104, United States

  • Nationwide Children's Hospital

    Columbus, Ohio, 43205, United States

  • Nicklaus Variety Children's Hospital

    Miami, Florida, 33155, United States

  • Primary Children's Hospital/University of Utah

    Salt Lake City, Utah, 84108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.